GGHC
Gilder Gagnon Howe & Co’s Arcus Biosciences RCUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-24,016
| Closed | -$189K | – | 252 |
|
|
2025
Q1 | $189K | Sell |
24,016
-95,034
| -80% | -$746K | ﹤0.01% | 229 |
|
|
2024
Q4 | $1.77M | Sell |
119,050
-7,336
| -6% | -$109K | 0.02% | 191 |
|
|
2024
Q3 | $1.93M | Sell |
126,386
-11,641
| -8% | -$178K | 0.02% | 186 |
|
|
2024
Q2 | $2.1M | Sell |
138,027
-36,628
| -21% | -$558K | 0.03% | 176 |
|
|
2024
Q1 | $3.3M | Buy |
174,655
+35,485
| +25% | +$670K | 0.04% | 168 |
|
|
2023
Q4 | $2.66M | Sell |
139,170
-99,362
| -42% | -$1.9M | 0.04% | 169 |
|
|
2023
Q3 | $4.28M | Sell |
238,532
-2,657
| -1% | -$47.7K | 0.07% | 153 |
|
|
2023
Q2 | $4.9M | Buy |
241,189
+13,078
| +6% | +$266K | 0.07% | 157 |
|
|
2023
Q1 | $4.16M | Sell |
228,111
-10,728
| -4% | -$196K | 0.07% | 142 |
|
|
2022
Q4 | $4.94M | Sell |
238,839
-2,388
| -1% | -$49.4K | 0.09% | 134 |
|
|
2022
Q3 | $6.31M | Buy |
241,227
+19,145
| +9% | +$501K | 0.11% | 122 |
|
|
2022
Q2 | $5.63M | Sell |
222,082
-69,198
| -24% | -$1.75M | 0.1% | 130 |
|
|
2022
Q1 | $9.19M | Sell |
291,280
-1,388
| -0.5% | -$43.8K | 0.09% | 145 |
|
|
2021
Q4 | $11.8M | Buy |
292,668
+1,665
| +0.6% | +$67.4K | 0.07% | 165 |
|
|
2021
Q3 | $10.1M | Sell |
291,003
-6,085
| -2% | -$212K | 0.05% | 197 |
|
|
2021
Q2 | $8.16M | Sell |
297,088
-7,124
| -2% | -$196K | 0.04% | 227 |
|
|
2021
Q1 | $8.54M | Sell |
304,212
-11,599
| -4% | -$326K | 0.05% | 212 |
|
|
2020
Q4 | $8.2M | Sell |
315,811
-554,823
| -64% | -$14.4M | 0.04% | 194 |
|
|
2020
Q3 | $14.9M | Buy |
870,634
+65,560
| +8% | +$1.12M | 0.09% | 149 |
|
|
2020
Q2 | $19.9M | Buy |
805,074
+784,944
| +3,899% | +$19.4M | 0.16% | 119 |
|
|
2020
Q1 | $279K | Sell |
20,130
-1,226
| -6% | -$17K | ﹤0.01% | 233 |
|
|
2019
Q4 | $216K | Buy |
21,356
+441
| +2% | +$4.46K | ﹤0.01% | 263 |
|
|
2019
Q3 | $190K | Buy |
20,915
+472
| +2% | +$4.29K | ﹤0.01% | 262 |
|
|
2019
Q2 | $163K | Buy |
+20,443
| New | +$163K | ﹤0.01% | 273 |
|